Doctor profile · Federal record
Dr. DAVID LEE, MD
Gastroenterology Physician (CMS: GASTROENTEROLOGY) · LINCOLN, NE
- NPI 1184774812
- Accepts Medicare
- MIPS 82.7 / 100 · 2023
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6900 L ST STE 1
LINCOLN, NE 685102478
(402) 441-5600
fax (402) 441-5606
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- December 23, 2021
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Nebraska #23261
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184774812. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
831
Distinct HCPCS
10
Medicare allowed
$132,521
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 283 | 281 | $232 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 91 | 84 | $84 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | 78 | $103 | |
G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk | 70 | 69 | $160 | |
43235 |
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | 53 | $96 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 54 | 54 | $152 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 47 | 47 | $101 | |
G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 47 | 47 | $159 | |
45378 |
Diagnostic exam of large bowel using a flexible endoscope | 38 | 37 | $169 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 31 | 29 | $120 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 428. This provider delivers 1.9× the peer median.Open Payments
Industry payments received
All-time total
$632
Transactions
19
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | 7 | $413.52 | |
| Celgene Corporation | 4 | $68.41 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67.93 | |
| ABBVIE INC. | 3 | $46.72 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17.96 | |
| Gilead Sciences, Inc. | 1 | $17.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
940
Patients
482
Total drug cost
$197,862
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates) | Brand | 301 | 296 | $24,287 |
| Omeprazole | Generic | 161 | 38 | $2,631 |
| Pantoprazole Sodium | Generic | 72 | 19 | $1,029 |
| Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl) | Brand | 70 | 69 | $1,223 |
| Suprep (Sodium, Potassium,mag Sulfates) | Brand | 64 | 60 | $7,567 |
| Mesalamine | Generic | 52 | 0 | $44,639 |
| Balsalazide Disodium | Generic | 37 | 0 | $5,966 |
| Mesalamine Er (Mesalamine) | Brand | 37 | 0 | $9,228 |
| Creon (Lipase/Protease/Amylase) | Brand | 31 | 0 | $75,998 |
| Famotidine | Generic | 26 | 0 | $592 |